ELAN
NYSE · Pharmaceuticals
Elanco Animal Health Inc
$23.90
-0.32 (-1.32%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.75%
1Y
+79.03%
YTD
+6.13%
Open$24.15
Previous Close$24.22
Day High$24.54
Day Low$23.88
52W High$27.72
52W Low$13.16
Volume—
Avg Volume5.68M
Market Cap12.10B
P/E Ratio—
EPS$-0.51
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$23.56
Above
SMA 200
$18.91
Above
RSI (14)
59.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+624.8% upside
Current
$23.90
$23.90
Target
$173.23
$173.23
$121.49
$173.23 avg
$230.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.74B | 4.64B | 2.45B |
| Net Income | -233,442,737 | -205,475,269 | 423.07M |
| Profit Margin | -4.9% | -4.7% | 17.2% |
| EBITDA | 342.07M | 317.82M | 874.42M |
| Free Cash Flow | — | — | 633.64M |
| Rev Growth | +2.3% | +2.3% | +2.6% |
| Debt/Equity | 0.61 | 0.61 | 0.94 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |